Kirkland & Ellis LLP
04/23/2025 | Press release | Distributed by Public on 04/23/2025 06:20
Kirkland Advises KKR on Financing for Recommended Public Offer of Biotage
Kirkland & Ellis is advising RWK Bidco AB, a newly formed company indirectly wholly owned by KKR Funds, on the financing for its recommended public offer to the shareholders of Biotage AB ("Biotage") to tender all ordinary shares in Biotage. The offer values Biotage at approximately SEK 11.607 billion. The completion of the offer is conditional upon, inter alia, receipt of regulatory clearances.
Biotage is a global supplier and solutions partner to a wide range of customers within drug discovery, development and analytical testing.
The Kirkland team includes debt finance lawyers Ian Barratt, Natasha Smith and Luca Misseroni.
Kirkland & Ellis LLP published this content on April 23, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 23, 2025 at 12:20 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]